Virax Biolabs Reports AGM Results
Ticker: VRAX · Form: 6-K · Filed: Dec 23, 2024 · CIK: 1885827
| Field | Detail |
|---|---|
| Company | Virax Biolabs Group Ltd (VRAX) |
| Form Type | 6-K |
| Filed Date | Dec 23, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, reporting, governance
TL;DR
Virax Biolabs filed its AGM results, confirming 20-F reporting for UK-based operations.
AI Summary
Virax Biolabs Group Ltd filed a Form 6-K on December 23, 2024, reporting results from its Annual General Meeting (AGM) held in December 2024. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. The company's principal executive offices are located in Lanarkshire, United Kingdom.
Why It Matters
This filing provides an update on the company's governance and operational reporting structure, confirming its status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing reporting AGM results and confirming reporting status, with no immediate financial or operational risks indicated.
Key Players & Entities
- Virax Biolabs Group Ltd (company) — Registrant
- December 2024 (date) — Reporting period for AGM results
- 20241223 (date) — Filing date
- Form 20-F (document) — Annual report filing requirement
- Lanarkshire, United Kingdom (location) — Principal executive offices
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing is to report the results of Virax Biolabs Group Ltd's Annual General Meeting (AGM) held in December 2024.
When was this Form 6-K filed?
This Form 6-K was filed on December 23, 2024.
Does Virax Biolabs Group Ltd file annual reports under Form 20-F or 40-F?
The filing indicates that Virax Biolabs Group Ltd files annual reports under Form 20-F.
Where are the principal executive offices of Virax Biolabs Group Ltd located?
The principal executive offices of Virax Biolabs Group Ltd are located at BioCity Glasgow, Bo'Ness Road, Newhouse, Lanarkshire, ML1 5UH, United Kingdom.
What is the significance of the 'Former Company' information?
The filing notes a former company name, 'Virax Biolabs (Cayman) Ltd', and a date of name change as '20210930', indicating a corporate restructuring or rebranding.
Filing Stats: 768 words · 3 min read · ~3 pages · Grade level 14.3 · Accepted 2024-12-23 08:50:58
Filing Documents
- 6-k_2024_agm_results.htm (6-K) — 48KB
- 0000950170-24-139294.txt ( ) — 49KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VIRAX BIOLABS GROUP LIMITED Date: December 23, 2024 By: /s/ James Foster James Foster, Chief Executive Officer